Clinical development

R&D

12 Questions with Matthew Goodman

LUCENT Biopharma's Medical Director Matthew Goodman, a doctor by training, specialises in late-phase Clinical Development and Medical Affairs.

Digital

Harnessing AI to future-proof biopharma

The biopharmaceutical industry has crossed the threshold into the AI era.

R&D

Clinical development rates are falling - but it’s not all ba...

Over the past decade, a shift has been occurring in biopharma R&D.

R&D

Partner Content

2nd ADC Toxicity Summit 2024

Improving Prediction & Translation of ADC Toxicities to Drive More Tolerable ADCs Successfully Into & Through Clinical Development

Digital

Digital tools must be used in pharma manufacturing to keep p...

The pace of change in drug discovery and clinical development has been unmatched in recent years, with technologies such as AI accelerating these processes.

R&D

Partner Content

GLP-1-Based Therapeutics Summit

Advancing Specialized, Durable, & Efficacious GLP-1s & Investigating Commercial Opportunity to Crystallize Pipeline Strategy & Indication Expansion